Dr. Aaron Falchook (PGY 5)

Education

  • Undergraduate:  University of Florida, Gainesville, FL
  • Medical School: University of Florida College of Medicine, Gainesville, FL
  • Internship:  University of North Carolina Hospitals, Chapel Hill, NC

 

Honors and Awards

Medical School:

    • Genevra Todd and Henry E. Meleney Award for outstanding academic achievement, 2009
    • International Medical Mission Service Award to the Dominican Republic, 2009

Residency:

    • ASCO Merit Award; Annual Meeting of the American Society of Clinical Oncology, June, 2013
    • ASTRO Scientific Abstract Award; Annual Meeting of the American Society for Radiation Oncology, September, 2013
    • ASCO Merit Award; Annual Meeting of the American Society of Clinical Oncology, June, 2014

     

    Research Interests

    Image guidance for prostate cancer; regional management of head and neck cancer; patterns of care and utilization of healthcare resources for surgical, medical, and radiation oncology treatment of malignancy

     

    Publications

    (as of 2/17/15)

    • Falchook AD, Hendrix LH, Chen RC. Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer. J Oncol Pract 2015 Feb 10. [Epub ahead of print], PMID: 25670199.
    • Falchook AD, Chen RC. Association between certificate of need legislation and radiation therapy use among elderly patients with early cancers. Int J Radiat Oncol Biol Phys 2015 Feb 1;91(2):448-450.  PMID: 25636768.
    • Falchook AD, Zevallos JP, Chera BS. Increased risk of salivary gland cancer among women with a previous cancer diagnosis. Head Neck 2015 Jan 12. [Epub ahead of print], PMID: 25581457.
    • Jagsi R, Falchook AD, Hendrix LH, Curry H, Chen RC. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Int J Radiat Oncol Biol Phys 2014 Dec 1;90(5):1001-1009. PMID: 25539365.
    • Mosaly PR, Mazur L, Miller S, Eblan M, Falchook A, Goldin G, Burkhart K, LaChapelle D, Adams R, Chera B, Marks LB. Application of human factors analysis and classification system model to event analysis in radiation oncology. Prac Rad Onc 2014 October 24. [Epub ahead of print], PMID: 25413409.
    • Falchook AD, Salloum RG, Hendrix LH, Chen RC. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs. Int J Radiat Oncol Biol Phys 2014;89(2):243-248. PMID: 24321784
    • Falchook A, Tepper J. Rectal cancer genomics. Semin Colon Rectal Surg 2014 Mar;25(1):13-18. DOI: 10.1053/j.scrs.2013.09.010
    • Falchook AD, Zagar TM. A case report of stereotactic radiosurgery in a patient with Ehlers-Danlos syndrome. Rep Pract Oncol Radiother 2013;18(4):241-244. PMID: 24416559.
    • Falchook A, Dagan R, Morris C, Mendenhall W. Elective neck dissection for second primary after previous definitive radiotherapy. Am J Otolaryngology 2013;33(2):199-204. PMID: 21658804.
    • Vargas C, Saito A, Hsi W, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J.  Cine-magnetic resonance imaging assessment of interfraction motion for prostate cancer patient supine or prone with and without a rectal balloon. Am J Clin Onc 2010;33:11-16.  PMID:19730351.
    • Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Onc 2009;32:180-186.  PMID: 19307953.
    • Yeung A, Vargas C, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall N, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for prostate cancer therapy. Int J Radiat Onc Biol Phys 2008;72:1426-1433. PMID: 18762391
    • Vargas C, Wagner M, Mahajan, C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, and Keole S. Proton therapy coverage for prostate cancer treatment. Int J Radiat Onc Biol Phys 2008;70:1492-1501. PMID:18374228.

     

    Meeting Abstracts/Presentations

    • Falchook A, Hendrix LH, VanderWalde NA, Zagar TM, Jones EL, Jagsi R, Chen RC. Adoption of hypofractionated radiotherapy (HyRT) for ductal carcinoma in situ (DCIS): A SEER-Medicare study. American Society of Clinical Oncology Quality Care Symposium, Boston, MA, Oct 18, 2014. (Oral presentation.) 
    • Falchook A, Chen RC. Association between certificate of need (CON) legislation and radiotherapy use among elderly patients with early cancers: a population-based examination. American Society of Clinical Oncology Quality Care Symposium, Boston, MA, Oct 18, 2014. (Poster presentation.)  
    • Falchook A, Hendrix LH, Curry HA, Chen RC, Jagsi R. Adoption of intensity modulated radiotherapy (IMRT) in early stage breast cancer patients receiving hypofractionated and conventionally fractionated radiation in the US. American Society for Radiation Oncology Annual Meeting, San Francisco, CA, Sept 14-17, 2014.  (Poster presentation.)
    • Mosaly PR, Mazur L, Miller SM, Eblan MJ, Falchook A, Goldin GH, Marks LB.  Assessing the applicability and reliability of the human factors analysis and classification system (HFACS) to the analysis of good catches in radiation oncology. American Society for Radiation Oncology Annual Meeting, San Francisco, CA, Sept 14-17, 2014.  (Poster presentation.) 
    • Falchook A, Hendrix L, VanderWalde N, Zagar T, Jones E, Jagsi R, Chen R. Adoption of hypofractionated radiotherapy (HyRT) for ductal carcinoma in situ (DCIS): a SEER-Medicare study. American Society of Clinical Oncology Annual Meeting, Chicago, IL June 3, 2014. (Oral presentation.)
    • Falchook AD, Hendrix LH, VanderWalde NA, Zagar TM, Jones E, Jagsi R, Chen RC. Adoption of hypofractionated radiotherapy for early-stage invasive breast cancer after publication of randomized trials.  American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 3, 2014. (Oral presentation.)
    • Mazur L, Mosaly P, Falchook A, Eblan M, Boyle M, Frohlich F, Marks L. Quantification of physicians' workload using eye-tracking and EEG-based data. Industrial and Systems Engineering Research Conference, Montreal, Canada, May 2014. (Oral presentation.)
    • Falchook A, Hendrix L, Chen R. Clinical implications of bone scan underuse for patients with high-risk prostate cancer (CaP). Poster Presentation at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, San Francisco, CA, January 30, 2014. (Poster presentation.)
    • Falchook AD, Salloum RG, Hendrix LH, Chen RC. Multiple pathology reviews in prostate cancer diagnosis, prevalence of use in the Medicare population and cost implications. (Abstract.)  American Society for Radiation Oncology Annual Meeting, Atlanta, GA, September, 2013. (Oral presentation.)
    • Falchook AD, Salloum RG, Hendrix LH, Chen RC. Use of bone scans during initial prostate cancer (CaP) workup, downstream procedures, and associated Medicare costs. (Abstract.)  American Society of Clinical Oncology Annual Meeting, Chicago, IL, June, 2013.  (Poster presentation.)
    • Yadava P, Falchook A, Hughes J.  Cationic sulfhydryl containing surfactant for siRNA delivery.  (Abstract.)  American Association of Pharmaceutical Scientists Annual Meeting, San Francisco, CA,  May, 2005. (Poster presentation.)